TC Group, LLC's Form 4 filing
Jasper Therapeutics, Inc. (JSPR) · filed Feb 12, 2024
- Accession no.
- 0000950170-24-014017
- Filed
- Feb 12, 2024, 6:23 PM ET
- Trade date
- Feb 8, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.46M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| TC Group, LLCCIK 0000933790 | 10% Owner |
| Carlyle Investment Management LLCCIK 0001354120 | 10% Owner |
| Abingworth LLPCIK 0001397144 | 10% Owner |
| Carlyle Group Inc.CIK 0001527166 | Other: Former 10% Owner |
| Carlyle Holdings I GP Inc.CIK 0001548626 | 10% Owner |
| Carlyle Holdings I GP Sub L.L.C.CIK 0001548627 | 10% Owner |
| Carlyle Holdings I L.P.CIK 0001548628 | 10% Owner |
| Abingworth Bioventures VII LPCIK 0001688313 | 10% Owner |
| CG Subsidiary Holdings L.L.C.CIK 0001790577 | 10% Owner |
| Carlyle Genesis UK LLCCIK 0001941860 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Voting Common Stock | PPurchaseAcquired | +190,000 | $12.95 | +$2,460,500 | 1,066,189 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.